AKT1 and amyotrophic lateral sclerosis: Collectively, our data demonstrate that IGF-2 can protect ALS patient motor neurons from degeneration in two different ALS-like toxicity systems and that PI3/Akt activation and subsequent GSK3β inhibition, mediated through IGF-1R binding, may in part mediate this protective effect.